)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Coloplast (COLO) investor relations material
Coloplast CMD 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.CMD 2025 summary2 Sep, 2025
Strategic context, direction, and organizational changes
Launched a new five-year strategy, Impact4, focused on customer-centricity, innovation, efficiency, and technology adoption, with a new Executive Leadership Team and two business units: Chronic Care and Acute Care.
Chronic Care includes ostomy, continence, bowel management, voice, and respiratory care; Acute Care covers urology, wound care, and Kerecis.
Strategy aims to help 4 million people long-term, foster a high-performance, sustainable culture, and develop future leaders.
Market fundamentals remain stable, driven by demographics and emerging markets, but healthcare reforms and local trends continue to impact growth.
AI and technology are prioritized as enablers for efficiency and customer experience improvements.
Financial guidance and performance targets
Five-year organic revenue CAGR target set at 7–8%, with EBIT growth in line with or above revenue, and ROIC ambition raised to over 20% by FY 2029/30.
Free cash flow to sales target set at a minimum of 20%, with CapEx ratio expected to decline to 4–5% as major facility investments conclude.
Dividend payout ratio expected to be in the 60–80% range, with share buybacks to resume within 2–3 years; leverage ratio targeted at 1.5x EBITDA.
Tax rate expected to remain around 22%, and NWC-to-sales ratio to improve to 24%.
No major M&A planned; focus remains on organic growth and smaller bolt-on acquisitions.
Business unit strategies and innovation
Chronic Care aims for above-market growth and profitability, expanding portfolios and leveraging new US reimbursement opportunities.
Wound and Tissue Repair, including Kerecis, targets double-digit growth and improved profitability, with ongoing integration and innovation.
Interventional Urology seeks mid- to high-single-digit growth, with Intevia and Intibia launches, and recovery from recent recalls.
Dynamic resource allocation prioritizes high-potential areas, with multiple product launches planned across business areas.
R&D is now represented in executive management to ensure innovation aligns with cost and margin objectives.
What drives organic growth beyond market expansion?
How will AI specifically elevate user experience?
Impact of new US Bowel Care reimbursement?
Which BUs are key to 7-8% organic growth?
How will ROIC reach >20% with EBIT growth?
How will services translate to value capture?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Coloplast earnings date
Q4 24/254 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Coloplast A/S engages in the development and sale of intimate healthcare products and services. The company offers urology products, such as bladder catheters, external urinary catheter systems, balloon dilators for benign prostatic hyperplasia treatment, stents and grafts, urological drainage bags, and colostomy bags; orthopedic products consisting of sheets with fixation areas, meshes with fixation areas and meshes marketed together with other devices.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage